328 related articles for article (PubMed ID: 21323814)
21. The potential role of dendritic cells in the therapy of Type 1 diabetes.
Lee CN; Lew AM; Wu L
Immunotherapy; 2013 Jun; 5(6):591-606. PubMed ID: 23725283
[TBL] [Abstract][Full Text] [Related]
22. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
Skak K; Haase C; Michelsen BK
Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
[TBL] [Abstract][Full Text] [Related]
23. [Is prevention of diabetes mellitus possible?].
Lehmann R; Spinas GA
Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
[TBL] [Abstract][Full Text] [Related]
24. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
26. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
27. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
28. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
29. Type 1 diabetes: etiology, immunology, and therapeutic strategies.
van Belle TL; Coppieters KT; von Herrath MG
Physiol Rev; 2011 Jan; 91(1):79-118. PubMed ID: 21248163
[TBL] [Abstract][Full Text] [Related]
30. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
Kakka R; Koda-Kimble MA
Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
Wang X; He Z; Ghosh S
Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
[TBL] [Abstract][Full Text] [Related]
32. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
34. The possibility that pancreatic beta cell destruction leading to type 1 diabetes is initiated by the release of cytokines by polyclonal activation of the immune system.
Ziegler M; Ziegler B
Exp Clin Endocrinol; 1990 Feb; 95(1):110-8. PubMed ID: 2139848
[TBL] [Abstract][Full Text] [Related]
35. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
Gorus FK
Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403
[TBL] [Abstract][Full Text] [Related]
36. [Etiopathogenesis of type 1 diabetes mellitus].
Timsit J
Rev Prat; 1996 Mar; 46(5):560-4. PubMed ID: 8815521
[TBL] [Abstract][Full Text] [Related]
37. Etiology and pathogenesis of type 1 diabetes.
Scherbaum WA
Horm Metab Res Suppl; 1992; 26():111-6. PubMed ID: 1490674
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy.
Sebastiani G; Vendrame F; Dotta F
Transplant Proc; 2011; 43(1):330-2. PubMed ID: 21335216
[TBL] [Abstract][Full Text] [Related]
39. [Latent autoimmune diabetes in adults: an update].
Zhou ZG; Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
[TBL] [Abstract][Full Text] [Related]
40. Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
Honkanen J; Skarsvik S; Knip M; Vaarala O
Diabetes Metab Res Rev; 2008; 24(8):635-41. PubMed ID: 18973208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
